FDX
41
11
NUE
51
3
CNP
44
5
CPB
30
5
ADI
45
-2
HAS
37
4
WEC
45
4
PX
66
4
TRV
48
2
AFL
41
4
MAS
59
3
MDLZ
38
2
CINF
40
5
UHS
58
2
BMY
43
2
OKE
68
4
DGX
36
3
CAT
59
4
FRT
41
5
NI
63
3
FDX
41
11
NUE
51
3
CNP
44
5
CPB
30
5
ADI
45
-2
HAS
37
4
WEC
45
4
PX
66
4
TRV
48
2
AFL
41
4
MAS
59
3
MDLZ
38
2
CINF
40
5
UHS
58
2
BMY
43
2
OKE
68
4
DGX
36
3
CAT
59
4
FRT
41
5
NI
63
3
Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
22

SAVA
Cassava Sciences

Last Price:
26.23
Seasonality Move:
36.31%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Cassava Sciences Price Quote

$26.23
+2.30 (+9.61%)
(Updated: November 6, 2024 at 2:25 PM ET)

Cassava Sciences Key Stats

Sell
22
Cassava Sciences (SAVA) is a Sell
Day range:
$23.46 - $25.71
52-week range:
$8.79 - $42.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
25.39
P/B ratio:
6.08%
Volume:
1.9M
Avg. volume:
1.7M
1-year change:
5.42%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-1.41

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went down by -11.63% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price rose by 5.42% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $207.3M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.94

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$86.2M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $125.2M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$92K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Biomarin Pharmaceutical Inc (BMRN)
    • Bristol-Myers Squibb Co (BMY)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • Eli Lilly and Co (LLY)
    • Seelos Therapeutics Inc (SEEL)

Cassava Sciences Dividend Yield

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -219.25%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 116.00
Upside from Last Price: 384.75%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    20.6M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders